Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis

被引：0
|
作者：
Nishimoto, N. [1 ]
Miyasaka, N. [2 ]
Yamamoto, K. [3 ]
Kawai, S. [4 ]
Takeuchi, T. [5 ]
Azuma, J. [6 ]
Kishimoto, T. [7 ]
机构：
[1] Osaka Univ, Grad Sch Frontier Biosci, Immune Lab Regulat, Suita, Osaka, Japan
[2] Tokyo Med & Dent Univ, Dept Med Rheumatol, Tokyo, Japan
[3] Univ Tokyo, Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[4] Toho Univ, Omori Med Ctr, Div Rheumatol, Tokyo, Japan
[5] Saitama Med Ctr, Saitama Med Sch, Dept Rheumatol & Clin Immunol, Kawagoe, Saitama, Japan
[6] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Evaluat Med & Therapeut, Suita, Osaka 565, Japan
[7] Osaka Univ, Grad Sch Frontier Biosci, Lab Immune Regulat, Osaka, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (10) : 1580 - 1584
  • [2] Tocilizumab - A humanized anti-IL-6 receptor monoclonal antibody for the treatment of rheumatoid arthritis
    Schlesselman, Lauren S.
    Hussey, Aaron P.
    [J]. FORMULARY, 2008, 43 (08) : 272 - 279
  • [3] Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis
    Miyagawa, Ippei
    Nakayamada, Shingo
    Saito, Kazuyoshi
    Hanami, Kentaro
    Nawata, Masao
    Sawamukai, Norifumi
    Nakano, Kazuhisa
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    [J]. MODERN RHEUMATOLOGY, 2014, 24 (03) : 405 - 409
  • [4] Long-Term Safety and Efficacy of Tocilizumab, an Anti- IL-6 Receptor Monoclonal Antibody, in Monotherapy, in Patients with Rheumatoid Arthritis (The STREAM Study): Evidence of Safety and Efficacy in a 5-Year Extension Study
    Dejaco, C.
    Duftner, C.
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2009, 16 (04): : 202 - 202
  • [5] Efficacy and safety of tocilizumab, an anti-IL-6 receptor monoclonal antibody; in patients with polyarticular or oligoarticular onset juvenile idiopathic arthritis.
    Imagawa, Tomoyuki
    Mori, Masaaki
    Takei, Syuji
    Kawano, Yoshifumi
    Iwata, Naomi
    Miyoshi, Mari
    Murata, Takuji
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    Yokota, Shumpei
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S168 - S168
  • [6] Clinical Efficacy of Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab in Patients with Neuromyelitis Optica
    Araki, Manabu
    Matsuoka, Takako
    Aranami, Toshimasa
    Nakamura, Masakazu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Yamamura, Takashi
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 911 - 912
  • [7] Efficacy and safety of tocilizumab in monotherapy, an anti-IL-6 receptor monoclonal antibody, in patients with active rheumatoid arthritis: Results from a 24 week double-blind phase III study
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    Kishimoto, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 59 - 59
  • [8] Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis
    Hashimoto, Motomu
    Fujii, Takao
    Hamaguchi, Masahide
    Furu, Moritoshi
    Ito, Hiromu
    Terao, Chikashi
    Yamamoto, Keiichi
    Yamamoto, Wataru
    Matsuo, Takashi
    Mori, Masato
    Ohmura, Koichiro
    Kawabata, Hiroshi
    Mimori, Tsuneyo
    [J]. PLOS ONE, 2014, 9 (05):
  • [9] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab in three patients with neuromyelitis optica
    Araki, M.
    Aranami, T.
    Matsuoka, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 417 - 417
  • [10] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab for the treatment of neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 947 - 947
12345